Insights › Market reaction

Why Artiva Biotherapeutics (ARTV) Stock Fell 4.36% in 10 Minutes on Oct 27, 2026

231,787 shares changed hands in those 10 minutes.

Published in ET: Feed time in ET: Company news ARTV -4.36% in 10 min after the headline
  • ARTV fell 4.36% in the 10 minutes after the 08:13:21 ET headline, from $4.35 to $4.16.
  • The headline crossed in pre-market trading, 1 hour 17 minutes before the 9:30 ET open.
  • Next earnings report on the calendar: Wednesday, November 11, 2026.
ARTV Why Artiva Biotherapeutics (ARTV) Stock Fell 4.36% in 10 Minutes on Oct 27, 2026
MoveSurge publish 08:13:21 ET
MoveSurge publish
08:13:21 ET
4.47 4.31 4.14 3.98 4.09 08:11 08:13 08:28
Real 1-minute OHLC candles around publish time. Chart times are New York ET; validated market data captured by MoveSurge.

Reaction by asset (real prices)

Asset2m beforeAt release+1m+10m+1m %+10m %
ARTV 4.35 4.35 4.32 4.16 -0.65% -4.36%

Artiva Biotherapeutics (ARTV) shares fell 4.36% in the 10 minutes after this headline reached the MoveSurge news feed at 08:13:21 ET on Tuesday, October 27, 2026: “Artiva Biotherapeutics to stop developing its lead experimental cell therapy after two patient deaths and reduce its workforce by 94%”

ARTV in the first 10 minutes

From a reference price of $4.35 just before the headline, the stock was down 0.65% after one minute and down 4.36%, at $4.16, after 10 minutes. The move kept building after the first minute. 231,787 shares changed hands in those 10 minutes. The headline crossed in pre-market trading, 1 hour 17 minutes before the 9:30 ET open.

Artiva Biotherapeutics at a glance

SectorHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
Market value$301 million (as of Oct 27, 2026)
Next earnings report on the calendarWednesday, November 11, 2026

Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.

What headline moved Artiva Biotherapeutics stock on October 27, 2026?

At 08:13:21 ET, this headline crossed: “Artiva Biotherapeutics to stop developing its lead experimental cell therapy after two patient deaths and reduce its workforce by 94%”. The stock fell 4.36% in the next 10 minutes.

How far did ARTV move after the headline?

From $4.35 just before the headline to $4.16 10 minutes later, a -4.36% move.

When does Artiva Biotherapeutics report earnings next?

The next report on the MoveSurge earnings calendar is Wednesday, November 11, 2026.

Sources

Never miss the next market-moving story

Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.

Create free accountGo real time Watch live headlines -- free
See live news
The next market-moving story will not wait

See the important story while it still matters.

Seven market specialists bring experience dating back to 2006. MoveSurge adds the speed, coverage, and clear format built for today’s market.

Core market coverageEquities, macro, currencies and commodities Clear in secondsThe story, source, context, and measured move together Built on evidenceReal headlines, timestamps, prices, and trusted sources
Go real time View the live feed Subscription renews automatically. Cancel before renewal. Information only—no trade calls.